Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2023 - 2025)

Lexaria Bioscience's Amortizatization of Intangibles history spans 4 years, with the latest figure at $1937.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 20.97% year-over-year to $1937.0; the TTM value through Nov 2025 reached $8533.0, down 5.78%, while the annual FY2025 figure was $9047.0, 35.6% up from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $1937.0 at Lexaria Bioscience, down from $2070.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2773.0 in Q1 2024 and bottomed at $67.0 in Q4 2023.
  • The 3-year median for Amortizatization of Intangibles is $2199.0 (2025), against an average of $1961.8.
  • The largest annual shift saw Amortizatization of Intangibles soared 3558.21% in 2024 before it decreased 20.97% in 2025.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $67.0 in 2023, then skyrocketed by 3558.21% to $2451.0 in 2024, then decreased by 20.97% to $1937.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Amortizatization of Intangibles are $1937.0 (Q4 2025), $2070.0 (Q3 2025), and $2199.0 (Q2 2025).